 prevent therapi first gastrointestin bleed patient cirrhosi result control trial compar propranolol sclerotherapi placebo propranolol endoscop sclerosi esophag varic approach prophylaxi first gastrointestin hemorrhag cirrhot patient twenty-six cirrhot patient esophag varic histori trial regardless graviti cirrhosi size esophag varic patient hepatocarcinoma cancer imposs follow-up previou treatment portal hypertens contraind beta-block random patient propranolol dose heart rate patient intravaric extravaric inject polidocanol control patient vitamin placebo patient interv entri trial group compar term clinic biolog paramet size esophag varic grade II iii child-pugh classif origin cirrhosi alcohol case twenty-four patient propranolol group endoscop sclerosi esophag varic group placebo group actuari estim kaplan-mei time onset first bleed differ signific propranolol placebo propranolol sclerotherapi sclerotherapi placebo